What Is Pseudogout?

Symptoms, Causes, Treatment, and More

Pseudogout, clinically referred to as calcium pyrophosphate deposition disease (CPPD), is a distinct form of arthritis. This condition arises when calcium pyrophosphate crystals form and accumulate within the joint spaces and surrounding connective tissues. While sharing symptomatic similarities with gout, another crystal-induced arthritis, pseudogout is fundamentally different, as gout involves uric acid crystals rather than calcium pyrophosphate. Understanding these distinctions is crucial for accurate diagnosis and effective management.

Episodes of pseudogout, commonly known as flares or flare-ups, manifest as acute bouts of joint swelling, intense pain, tenderness, redness, and warmth. These inflammatory events can significantly impact daily life, causing considerable discomfort. Although pseudogout frequently affects larger joints such as the knees and wrists, it has the potential to involve any joint in the body. Due to its inflammatory nature, pseudogout can sometimes be mistaken for other forms of arthritis that also present with similar signs of inflammation, making precise differentiation essential for proper care.

wutwhanfoto / Getty Images

Pseudogout Symptoms

The knee is the joint most frequently impacted by pseudogout, with the wrist being the second most common site. However, the condition can also inflame the hand joints and the metatarsophalangeal joint at the base of the big toe. When the big toe is inflamed, pseudogout may be mistakenly identified as gout, given that severe inflammation of this joint is a hallmark characteristic of a gout attack. Recognizing these subtle differences is key to proper diagnosis.

Pseudogout can present with varying degrees of severity, broadly categorized into three distinct types. The first is acute arthritis flares, typically affecting a single joint with intense inflammation and discomfort. The second type involves chronic, long-term inflammation that affects multiple joints, though often with less intensity than acute flares. The third, and arguably most destructive, is rapidly progressive degeneration of cartilage, the smooth, white tissue cushioning bone ends within joints. Each type requires a tailored approach to management and treatment.

Episodes characterized by sharp joint pain, noticeable swelling, redness, tenderness to the touch, and warmth are typical manifestations of pseudogout flares. In some cases, a fever may also accompany these acute inflammatory periods, indicating a systemic response to the crystal deposition. These symptoms can be debilitating, often appearing suddenly and persisting for varying durations, depending on the severity and specific characteristics of the flare. Prompt recognition of these signs is vital for initiating timely treatment.

Chronic pseudogout typically involves inflammation that affects several joints simultaneously. This widespread inflammation is generally less severe than an acute flare in a single joint but covers a broader area, leading to more persistent discomfort. If chronic pseudogout manifests in multiple joints, it might be misdiagnosed as rheumatoid arthritis (RA). RA is an autoimmune form of arthritis characterized by the immune system attacking the synovial linings of joints, leading to progressive and often severe joint destruction. Differentiating between these conditions is critical for appropriate long-term management.

For individuals living with chronic pseudogout, the ongoing presence of inflammation can lead to a range of symptoms that significantly impact their quality of life. These frequently include persistent joint pain and swelling, which can limit movement and function. Affected joints often exhibit stiffness, particularly noticeable in the mornings, taking time to loosen up. Reduced joint function can hinder daily activities, and generalized fatigue is a common accompanying symptom, reflecting the body's ongoing battle with inflammation.

The rapidly progressive form of pseudogout can lead to significant joint damage, similar to what is observed in advanced osteoarthritis (OA). OA is a degenerative joint disease primarily associated with aging and the cumulative wear and tear on joints. In this severe manifestation of pseudogout, the presence of calcium pyrophosphate crystals contributes to a swift deterioration of the cartilage lining. Unlike other forms of pseudogout, this type involves less overt inflammation, yet the underlying crystal deposition causes accelerated structural degradation, with the knee joint being the most commonly affected site.

Pseudogout vs. Gout

While pseudogout and gout share a misleadingly similar name and overlapping symptoms, they are distinct conditions driven by different underlying mechanisms. Understanding these differences is paramount for accurate diagnosis and effective treatment. Both involve crystal deposition in joints, but the chemical composition of these crystals and their typical presentation diverge significantly, leading to varying clinical approaches and management strategies.

Gout is caused by abnormally high levels of uric acid in the blood, leading to the formation and buildup of uric acid crystals within a joint, resulting in acute swelling and intense pain. In contrast, pseudogout is attributed to the accumulation of calcium pyrophosphate (CPP) crystals, which primarily deposit within the joint cartilage, triggering inflammation and pain. This fundamental difference in crystal composition dictates the diagnostic methods and therapeutic interventions for each condition, highlighting the importance of precise identification.

The patterns of joint involvement also differ notably between the two conditions. Pseudogout frequently affects multiple joints, with the knees and wrists being the most commonly implicated. Conversely, gout typically impacts one joint at a time, most often beginning with a severe attack in the big toe. While gout can eventually involve other joints, including the knees and wrists, its initial presentation is characteristically monoarticular, distinguishing it from the polyarticular nature often seen in pseudogout.

Another distinguishing factor lies in the timing and triggers of flare-ups. Pseudogout flares can occur at any time of day or night, often without clear preceding events. In contrast, gout flares have a strong tendency to begin suddenly in the middle of the night, frequently waking individuals from sleep. Furthermore, gout flares are often linked to specific triggers, such as dietary choices (e.g., consumption of red meat, seafood, alcohol), periods of stress, or certain medications, whereas pseudogout typically does not exhibit such discernible triggers.

Regarding pain severity and duration, there are also notable differences. The pain associated with pseudogout can be profound and tends to last longer than the intense, but often shorter-lived, pain experienced during a gout flare. Gout attacks, while exquisitely painful, often resolve within days to a week. Pseudogout episodes, however, can persist for several days to a few weeks, leading to more prolonged discomfort and functional impairment, underscoring the chronic burden these crystals can impose on joint health.

Why Does Pseudogout Flare?

According to a 2018 report published in the New England Journal of Medicine, pseudogout affects a significant portion of the adult population in the United States and Europe, with prevalence rates ranging between 4% and 7%. While the precise cause of pseudogout remains unknown, it is strongly associated with aging, becoming notably more common in older adults, particularly those assigned male at birth. This suggests that the cumulative effects of time on joint health may play a critical role in its development.

Pseudogout is largely considered a disease of aging, with its occurrence being rare in individuals under 60 years old. The prevalence of the condition consistently increases with advancing age, highlighting a clear demographic trend. Interestingly, calcium pyrophosphate crystals can sometimes exist within joint cartilage without causing any noticeable symptoms. Symptoms only emerge when these crystals are dislodged from the cartilage tissues and subsequently released into the surrounding joint fluid and spaces, triggering an inflammatory response.

Stress, concurrent illnesses, physical injury, or surgical procedures are recognized as potential catalysts that can trigger an episode of pseudogout. These events may disrupt the joint environment, leading to the release of dormant calcium pyrophosphate crystals and initiating an inflammatory flare. While a specific trigger may not always be identifiable, these incidents are frequently reported prior to the onset of symptoms. In most instances, pseudogout attacks are self-limiting, typically resolving within a few days to a few weeks, even without direct intervention.

Beyond acute triggers, previous trauma to a joint is also identified as a significant risk factor for pseudogout, especially affecting the meniscus of the knee. The history of injury can predispose the joint to crystal formation or release. Furthermore, pseudogout may develop following various surgical interventions or other injuries to bones, joints, and surrounding soft tissues. These traumatic events are thought to create an environment conducive to crystal deposition or their subsequent mobilization, leading to symptomatic flares.

Several underlying medical conditions are also recognized as additional risk factors that can predispose individuals to pseudogout. These include thyroid disease, such as hypothyroidism, which can affect metabolic processes. Kidney failure is another significant risk factor, as impaired kidney function can disrupt calcium and phosphate balance in the body. Various calcium disorders, including hyperparathyroidism, can also increase the likelihood of crystal formation. Furthermore, certain metabolic disorders may also contribute to the development of pseudogout.

There is a recognized genetic component to pseudogout, with a family history of the condition increasing an individual's susceptibility. When pseudogout runs in families, it may manifest in adults at a younger age, sometimes in middle age, rather than exclusively in older adults. Specifically, the ANKH gene has been linked to pseudogout; this gene is responsible for controlling cellular proteins involved in transporting pyrophosphate out of the body. A mutation in the ANKH gene can disrupt this process, causing CPP crystals to remain within the body and accumulate in the joints, leading to disease.

While the ANKH gene is the most prominent genetic link, other genes, including mutations of CCAL1 and CCAL2, have also been associated with the development of pseudogout. However, these genetic connections are considerably rarer. It's important to note that, unlike gout, diet typically plays no direct role in the onset or progression of pseudogout. Therefore, dietary modifications are not considered triggers for flare-ups of this specific condition, distinguishing it from other crystal-induced arthropathies where dietary factors are often implicated.

Although pseudogout is not classified as an autoimmune disease—meaning the immune system does not mistakenly attack healthy tissues—it undeniably provokes an inflammatory response from the immune system. This response manifests as arthritis, characterized by joint pain and swelling, and synovitis, which is the inflammation of the joint lining. The body's immune system reacts to the presence of the calcium pyrophosphate crystals as foreign invaders, triggering a cascade of inflammatory processes that ultimately lead to the painful symptoms experienced during a flare.

Getting Pseudogout Diagnosed

An early and precise diagnosis of pseudogout is paramount for preventing significant and potentially irreversible damage to joints and cartilage. Given that pseudogout can closely mimic the symptoms of other prevalent forms of arthritis, including rheumatoid arthritis (RA), osteoarthritis (OA), and especially gout, there is a substantial risk of misdiagnosis and subsequent delays in appropriate treatment. The sooner an individual seeks medical attention for persistent joint symptoms, the greater the likelihood of receiving timely and effective care, thus minimizing long-term complications.

If you are experiencing persistent joint pain, swelling, and stiffness, it is highly advisable to consult with a rheumatologist. A rheumatologist is a medical specialist uniquely trained in the diagnosis and treatment of arthritis and a wide spectrum of other rheumatic conditions. Their expertise allows for a comprehensive evaluation of your symptoms, a thorough understanding of your medical history, and the targeted diagnostic tests necessary to accurately identify the underlying cause of your joint discomfort, including conditions like pseudogout.

When healthcare providers suspect pseudogout, their diagnostic process typically begins with a detailed inquiry into your symptoms. This includes understanding their onset, duration, and any patterns or aggravating factors. They will also gather a comprehensive personal medical history and family history, as genetic predispositions and comorbidities can be relevant. To further evaluate the affected joints, various imaging techniques are often requested, such as X-rays, ultrasound, computed tomography (CT) scans, and magnetic resonance imaging (MRI) scans, which can reveal characteristic signs of crystal deposition or joint damage.

A pivotal diagnostic procedure for confirming pseudogout is joint aspiration, also known as arthrocentesis. This involves a healthcare provider using a sterile needle to carefully withdraw a small sample of synovial fluid from the affected joint. This fluid is then sent to a specialized laboratory for analysis. The laboratory examination meticulously searches for the presence of calcium pyrophosphate crystals, which are definitively diagnostic of pseudogout. Synovial fluid aspiration and subsequent crystal analysis are considered the gold standard for diagnosing this condition, offering a conclusive identification of the underlying cause of inflammation.

In addition to joint fluid analysis, blood and urine tests may also be conducted as part of the diagnostic workup. While these tests do not directly confirm pseudogout, they serve a crucial role in ruling out other conditions that might present with similar symptoms, such as rheumatoid arthritis. For instance, blood tests can check for inflammatory markers or specific antibodies that are indicative of autoimmune diseases, helping to differentiate pseudogout from other forms of inflammatory arthritis and guiding the most appropriate course of treatment.

Misdiagnosis

Pseudogout is unfortunately prone to misdiagnosis, which can lead to inappropriate or delayed treatment, potentially exacerbating joint damage and prolonging patient suffering. Its symptom profile often overlaps significantly with several other arthritic conditions, creating diagnostic challenges for healthcare providers. The nuanced differences in presentation and underlying mechanisms require careful consideration to ensure that the correct diagnosis is made.

Pseudogout is frequently confused with other forms of arthritis, leading to diagnostic errors. Chief among these is gout, due to the similar crystal-induced inflammatory nature, although the underlying crystals are different. It is also commonly mistaken for rheumatoid arthritis, especially in its chronic, multi-joint presentation, which shares features like swelling and stiffness. Osteoarthritis, a degenerative condition, can also be confused with pseudogout, particularly when pseudogout leads to rapid cartilage breakdown. Additionally, septic arthritis, a serious joint infection, can produce similar acute symptoms, requiring urgent differentiation due to its distinct and potentially life-threatening treatment needs.

Pseudogout Treatment Options

Managing pseudogout episodes effectively involves several therapeutic approaches aimed at alleviating pain and reducing inflammation. Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil or Motrin) and naproxen (Aleve) are typically the first line of treatment. These medications work by inhibiting the body's inflammatory response, thereby controlling pain and swelling during an acute flare. For individuals experiencing severe pseudogout attacks or those affecting multiple joints, corticosteroid drugs are often prescribed. These can be administered orally or directly injected into the affected joint, providing potent anti-inflammatory effects and rapid relief.

To prevent future pseudogout attacks and reduce their frequency, healthcare providers may prescribe a low-dose regimen of Colcrys (colchicine). Colchicine is a medication that has demonstrated efficacy in blocking the formation of crystals, both calcium pyrophosphate crystals linked to pseudogout and uric acid crystals associated with gout. Its preventive action helps to mitigate the underlying mechanism that triggers these inflammatory episodes. Regular, low-dose use can be a cornerstone of long-term management for individuals prone to recurrent flares, significantly improving their quality of life.

For patients suffering from chronic pseudogout, where inflammation persists across multiple joints, more advanced treatment options akin to those used for autoimmune arthritis may be considered. Medications such as hydroxychloroquine and methotrexate, which are classified as disease-modifying antirheumatic drugs (DMARDs), can be prescribed. These powerful medications work to reduce overall swelling and slow down the systemic processes within the body that contribute to chronic inflammation. By modulating the immune response and inflammatory pathways, DMARDs aim to provide more sustained control over the disease activity and protect joints from further damage.

In certain cases, direct intervention into the affected joint, known as joint drainage or aspiration, can offer significant relief from pain and pressure during a pseudogout flare. This procedure involves carefully inserting a needle into the joint space to withdraw excess synovial fluid, which often contains a concentration of calcium pyrophosphate crystals. After the fluid is removed, a numbing medication is typically administered, followed by an injection of a corticosteroid directly into the joint. This localized corticosteroid delivery works to reduce inflammation precisely where it is most needed, providing immediate and targeted relief.

Should the aforementioned medical treatments prove insufficient in preventing progressive joint damage, surgical intervention may become a necessary consideration. In cases where the accumulation of calcium pyrophosphate crystals and subsequent chronic inflammation have led to extensive and irreparable joint destruction, surgery can be performed to repair or replace the severely damaged joints. This option is typically reserved for advanced stages of the disease when other therapeutic avenues have been exhausted and the structural integrity and function of the joint are severely compromised.

While diet plays no direct role in the formation of the calcium pyrophosphate crystals that cause pseudogout, adopting an anti-inflammatory diet can significantly support overall joint health and potentially help manage systemic inflammation. This dietary approach focuses on eliminating foods known to promote inflammation within the body. Specifically, it is advisable to minimize or avoid sources of trans fats, such as margarine and certain polyunsaturated vegetable oils, as well as highly processed junk foods, baked goods high in refined sugars, and excessive alcohol consumption, all of which can contribute to inflammatory processes.

Conversely, an anti-inflammatory diet emphasizes the inclusion of nutrient-dense foods known for their anti-inflammatory properties. Incorporating fatty fish, which are rich in omega-3 fatty acids, can help reduce inflammation. A generous intake of various fruits and vegetables, packed with antioxidants and phytochemicals, is also beneficial. Certain spices, like turmeric, renowned for its potent anti-inflammatory compound curcumin, can be a valuable addition. Furthermore, using olive oil as a primary fat source provides healthy monounsaturated fats and anti-inflammatory compounds, contributing to a holistic approach to managing the body's inflammatory responses.

How to Manage Pseudogout Flares

When a pseudogout flare occurs, there are several effective strategies you can employ at home to manage symptoms and alleviate discomfort. Over-the-counter nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen sodium, are readily available and can be highly effective in reducing both pain and inflammation associated with the flare. It is crucial to follow dosage instructions carefully and consult a healthcare provider if you have any pre-existing conditions or are taking other medications.

Beyond oral medications, several additional measures can significantly ease discomfort during a flare. Applying cold compresses directly to the affected joint helps to reduce swelling and numb the area, providing immediate symptomatic relief. Resting the affected joint is also paramount; minimizing its use allows the inflammation to subside more effectively and prevents further irritation. Elevating the affected joint, by lying down and placing a pillow underneath it, can further assist in reducing swelling by promoting fluid drainage away from the inflamed area.

If at-home treatments prove insufficient in alleviating your symptoms or if your condition worsens, it is imperative to contact a healthcare provider promptly. They possess the expertise to assess your situation and may prescribe stronger medications, such as a more potent NSAID or a corticosteroid, which can be more effective in managing severe pain and inflammation. Professional medical guidance ensures that your treatment plan is optimized for your specific needs and the intensity of your flare, preventing prolonged discomfort and potential complications.

Furthermore, it is advisable to inform your healthcare provider if you experience frequent or particularly severe pseudogout flares, even if you can manage them at home. Recurring episodes may indicate an underlying issue that requires more comprehensive intervention. In such cases, your provider can reassess your diagnosis and treatment strategy, potentially prescribing medications designed to prevent future crystal build-up or to control the broader inflammatory processes within your body that contribute to these attacks. Proactive management is key to minimizing the long-term impact of pseudogout on your joints.

Summary

Pseudogout is a specific type of arthritis characterized by the accumulation of calcium pyrophosphate crystals within the joints and surrounding tissues. While the precise cause of this condition remains unknown, the risk of developing pseudogout significantly increases with age. Moreover, there is a recognized genetic predisposition, with the condition sometimes running in families. Pseudogout may also be linked to previous joint injury or certain systemic health conditions, including kidney disease or thyroid disorders, highlighting a complex interplay of factors contributing to its onset.

The hallmark of pseudogout is its presentation in periods of acute flare-ups, during which symptoms intensify dramatically. These characteristic symptoms include notable swelling, intense pain, tenderness upon touch, and warmth in the affected joints. Although pseudogout can manifest in any joint, the knees and wrists are the most commonly affected sites, experiencing the brunt of the crystal-induced inflammation. Recognizing these symptoms early is crucial for prompt intervention and effective management of the condition.

Pseudogout is categorized based on its severity and the number of joints it affects, allowing for a tailored diagnostic and treatment approach. It can present as an acute condition, impacting only a few joints with intense inflammation. Alternatively, it may manifest as a chronic form, affecting multiple joints with persistent, though often less severe, inflammation. In its most destructive form, pseudogout can be rapidly progressive, leading to significant and accelerated damage to cartilage and the overall joint structure, underscoring the potential for long-term complications.

If you suspect you might be experiencing symptoms consistent with pseudogout, it is highly advisable to contact a healthcare provider without delay. Early diagnosis and intervention are vital to avoiding long-term and potentially irreversible damage to the affected joints. Prompt medical evaluation allows for accurate identification of the condition, differentiation from other forms of arthritis, and the initiation of appropriate treatment, thereby preserving joint function and mitigating the chronic impact of crystal deposition.

Currently, there is no definitive cure for pseudogout, meaning the condition cannot be entirely eliminated. However, it can be effectively managed with various medications designed to alleviate symptoms during flares and prevent future recurrences. When experiencing a pseudogout episode, practical home management strategies include prioritizing rest for the affected joint, elevating it to reduce swelling, applying ice compresses for discomfort, and taking over-the-counter NSAIDs to manage pain and inflammation. These measures can provide significant relief during acute attacks.

It is crucial to maintain open communication with your healthcare provider, especially if you experience frequent or severe pseudogout flare-ups. These persistent or intense episodes warrant a reevaluation of your treatment plan. Your provider can assess your current condition, consider additional diagnostic tests, and potentially prescribe more advanced medications. These may include treatments aimed at preventing further crystal build-up or controlling underlying inflammatory processes, ensuring that your management strategy is optimized to minimize the impact of pseudogout on your daily life and joint health.

Read more:

• Health A-Z
• Arthritis
• More Arthritis Types & Related Conditions

8 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.

1. American Society for Surgery of the Hand. Pseudogout.
2. Cowley S, McCarthy G. Diagnosis and treatment of calcium pyrophosphate deposition (CPPD) disease: a review. Open Access Rheumatol. 2023;15:33-41. doi:10.2147/OARRR.S389664
3. Centers for Disease Control and Prevention. Gout.
4. Rosenthal AK, Ryan LM. Calcium pyrophosphate deposition disease. N Engl J Med. 2016;374(26):2575-2584. doi:10.1056/NEJMra1511117
5. Williams CJ, Qazi U, Bernstein M, et al. Mutations in osteoprotegerin account for the CCAL1 locus in calcium pyrophosphate deposition disease. Osteoarthritis Cartilage. 2018;26(6):797-806. doi:10.1016/j.joca.2018.03.005
6. Iqbal SM, Qadir S, Aslam HM, Qadir MA. Updated treatment for calcium pyrophosphate deposition disease: an insight. Cureus. 2019;11(1):e3840. doi:10.7759/cureus.3840
7. George MP, Ernste FC, Tande A, Osmon D, Mabry T, Berbari EF. Clinical presentation, management, and prognosis of pseudogout in joint arthroplasty: a retrospective cohort study. J Bone Jt Infect. 2019;4(1):20-26. doi:10.7150/jbji.29983
8. Harvard Health Publishing. An anti-inflammatory diet may be good for your joints.